Drug Safety

Consumer Adverse Drug Reaction Reporting: A New Step in Pharmacovigilance?
pp. 211-217(7)
Authors: van Grootheest K.; de Graaf L.; Berg L.T.W.d.J-v.d.

What Can Consumer Adverse Drug Reaction Reporting Add to Existing Health Professional-Based Systems?: Focus on the Developing World
pp. 219-225(7)
Authors: Fernandopulle R.B.M.; Weerasuriya K.

Benefits and Risks of Newer Treatments for Chemotherapy-Induced and Postoperative Nausea and Vomiting
pp. 227-259(33)
Author: Kovac A.L.

New Drugs for Insomnia: Comparative Tolerability of Zopiclone, Zolpidem and Zaleplon
pp. 261-282(22)
Authors: Terzano M.G.; Rossi M.; Palomba V.; Smerieri A.; Parrino L.

Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection
pp. 283-291(9)
Authors: Lacaze-Masmonteil T.; Seidenberg J.; Mitchell I.; Cossey V.; Cihar M.; Csader M.; Baarsma R.; Valido M.; Pollack P.F.; Groothuis J.R.